LVW Advisors LLC Purchases New Position in The Clorox Company (NYSE:CLX)

LVW Advisors LLC purchased a new stake in The Clorox Company (NYSE:CLXFree Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 1,610 shares of the company’s stock, valued at approximately $247,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. Choreo LLC boosted its holdings in shares of Clorox by 12.8% in the fourth quarter. Choreo LLC now owns 5,741 shares of the company’s stock valued at $819,000 after acquiring an additional 652 shares during the period. abrdn plc boosted its holdings in shares of Clorox by 20.1% in the fourth quarter. abrdn plc now owns 198,250 shares of the company’s stock valued at $28,268,000 after acquiring an additional 33,135 shares during the period. Savoir Faire Capital Management L.P. boosted its holdings in shares of Clorox by 61.8% in the fourth quarter. Savoir Faire Capital Management L.P. now owns 65,192 shares of the company’s stock valued at $9,296,000 after acquiring an additional 24,897 shares during the period. Game Plan Financial Advisors LLC acquired a new stake in shares of Clorox in the first quarter valued at approximately $1,025,000. Finally, Banque Cantonale Vaudoise boosted its holdings in shares of Clorox by 78.2% in the first quarter. Banque Cantonale Vaudoise now owns 29,335 shares of the company’s stock valued at $4,492,000 after acquiring an additional 12,872 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Trading Down 0.1 %

Clorox stock opened at $136.47 on Monday. The stock has a market cap of $16.95 billion, a PE ratio of 70.71, a P/E/G ratio of 2.19 and a beta of 0.39. The stock has a 50-day moving average price of $136.95 and a 200 day moving average price of $143.79. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.14. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The firm had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter last year, the business posted $1.51 EPS. The firm’s quarterly revenue was down 5.3% compared to the same quarter last year. Equities research analysts predict that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft decreased their price objective on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Citigroup cut their price objective on Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Evercore ISI cut their price objective on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday, May 1st. BNP Paribas initiated coverage on Clorox in a research report on Monday, June 24th. They issued an “underperform” rating and a $130.00 price objective for the company. Finally, UBS Group cut their price objective on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Five research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $145.33.

Read Our Latest Research Report on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.